Objective To develop a disease activity index for patients with primary Sjögren's syndrome (SS):
the European League Against Rheumatism (EULAR) Sjögren's syndrome disease …

Objectives: To assess the risk of lymphoproliferative disease or other malignancy (standardised
incidence ratios (SIRs)), in patients with primary Sjögren’s syndrome according to the …

Sjögren syndrome (SjS) is a systemic autoimmune disease that primarily affects the exocrine
glands (mainly the salivary and lacrimal glands) and results in the severe dryness of …

Objective The development of non-Hodgkin's lymphoma (NHL) confers a high risk of
mortality in primary Sjögren's syndrome (pSS) patients, but the sensitivity and specificity of …

Objectives To develop a score for assessment of patients' symptoms in primary Sjögren's
syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI). Methods Dryness, pain, …

Objective. This study was undertaken to analyze standardized mortality ratios (SMRs) and
causes and predictors of death in primary Sjögren’s syndrome (SS) diagnosed according to 3 …

The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) is a systemic disease
activity index that was designed to measure disease activity in patients with primary SS. With …

Objectives To define disease activity levels, minimal clinically important improvement (MCII)
and patient-acceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) …

Objectives To validate the two recently developed disease activity indexes for assessment of
primary Sjögren's syndrome (SS): the European League Against Rheumatism (EULAR) SS …

Objective. To reach a European consensus on the definition and characterization of the main
organ-specific extraglandular manifestations in primary SS. Methods. The EULAR-SS Task …